Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo
The interaction of latex microspheres with mouse Peyer's patch membranous M-cells was studied in a mouse gut loop model after the microspheres were coated with a variety of agents. Carboxylated microspheres (diameter 0.5 μm) were covalently coated with lectins Ulex europaeus 1, Concanavalin A,...
Gespeichert in:
Veröffentlicht in: | Vaccine 1998-03, Vol.16 (5), p.536-541 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The interaction of latex microspheres with mouse Peyer's patch membranous M-cells was studied in a mouse gut loop model after the microspheres were coated with a variety of agents. Carboxylated microspheres (diameter 0.5 μm) were covalently coated with lectins
Ulex europaeus 1,
Concanavalin A, Euonymus europaeus and
Bandeiraea simplicifolia 1 isolectin-B
4, human immunoglobulin A or bovine serum albumin. Of the treatments examined, only
Ulex europaeus (UEA1) resulted in significant selective binding of microspheres to M-cells. UEA1-coated microspheres bound to M-cells at a level 100-fold greater than BSA-coated microspheres, but binding to enterocytes was unaffected. Incubation of UEA1-coated microspheres with α-L-fucose reduced M-cell binding to a level comparable with BSA-coated microspheres. This indicated that targeting by UEA1 was via a carbohydrate receptor on the M-cell surface. Adherence of UEA1-coated microspheres to M-cells occurred within 10 min of inoculation into mouse gut loops and UEA1-coated microspheres were transported to 10 μm below the apical surface of M-cells within 60 min of inoculation. UEA1-coated microspheres also targeted mouse Peyer's patch M-cells after intragastric administration. These results demonstrated that altering the surface chemistry of carboxylated polystyrene microspheres increased M-cell targetting, suggesting a strategy to enhance delivery of vaccine antigens to the mucosal immune system. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/S0264-410X(97)00222-3 |